← Back to Search

Level 2 for Bipolar Disorder (MoodSwings 2 Trial)

N/A
Waitlist Available
Led By Patricia Suppes, MD, PhD
Research Sponsored by VA Palo Alto Health Care System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes from baseline to 3 months, 6 months,9months and 12 months
Awards & highlights

MoodSwings 2 Trial Summary

The investigators hope to learn whether access to online support and education can help people with Bipolar Disorder (BD) better manage their symptoms of depression.

Eligible Conditions
  • Bipolar Disorder

MoodSwings 2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes from baseline to 3 months, 6 months,9months and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes from baseline to 3 months, 6 months,9months and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Montgomery Asberg Rating Scale (MADRS) for Depression
Young Mania Rating Scale
Secondary outcome measures
Cornell Service Index (CSI)
Medical Outcomes Study Social Support Survey( MOS-SSS)
Medication Adherence rating Scale( MARS)
+5 more
Other outcome measures
Inventory Of Stigma Experiences
Motivation for Treatment Questionnaire - 8 item ( MTQ 8)

MoodSwings 2 Trial Design

3Treatment groups
Active Control
Group I: Level 2Active Control2 Interventions
Moderated discussion board plus psychoeducation
Group II: Level 3Active Control3 Interventions
Moderated discussion board plus psychoeducation plus interactive psychosocial tools
Group III: Level 1Active Control1 Intervention
Moderated discussion board only

Find a Location

Who is running the clinical trial?

University of MelbourneOTHER
167 Previous Clinical Trials
1,288,000 Total Patients Enrolled
2 Trials studying Bipolar Disorder
700,304 Patients Enrolled for Bipolar Disorder
VA Palo Alto Health Care SystemLead Sponsor
87 Previous Clinical Trials
56,563 Total Patients Enrolled
3 Trials studying Bipolar Disorder
535 Patients Enrolled for Bipolar Disorder
Patricia Suppes, MD, PhDPrincipal InvestigatorVA Palo Alto Health Care System & Stanford University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~26 spots leftby May 2025